Crown LiquidationCo NV in liquidatie (CNTGF)

Currency in USD
0.060
0.000(0.00%)
Delayed Data·
CNTGF Scorecard
Full Analysis
Stock generally trades with high price volatility
CNTGF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0600.060
52 wk Range
0.0100.705
Key Statistics
Prev. Close
0.06
Open
0.06
Day's Range
0.06-0.06
52 wk Range
0.01-0.705
Volume
-
Average Volume (3m)
14.86K
1-Year Change
-78.95%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNTGF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Crown LiquidationCo NV in liquidatie Company Profile

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, interpret, and report genomic variants for rare disease diagnostics; FilterTool, a web-based application for genetic data interpretation; and NEW CentoGenome, a Next Generation Sequencing (NGS)-based assay that provides diagnostic information to accelerate access to potential treatment options. The company also offers target and drug screening, clinical development, and market access and expansion, as well as CENTOGENE Biodatabank licenses and insight reports. In addition, it provides early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services, such as whole exome sequencing, whole genome sequencing, and multiomic testing solutions to physicians, laboratories, and hospitals directly or through distributors. The company was founded in 2006 and is headquartered in Rostock, Germany.

Compare CNTGF to Peers and Sector

Metrics to compare
CNTGF
Peers
Sector
Relationship
P/E Ratio
0.0x−0.1x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.9x2.6x
Price / LTM Sales
0.0x1.0x3.3x
Upside (Analyst Target)
0.0%53.2%42.8%
Fair Value Upside
Unlock17.4%6.5%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CNTGF Income Statement

FAQ

What Stock Exchange Does Crown LiquidationCo NV in liquidatie Trade On?

Crown LiquidationCo NV in liquidatie is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Crown LiquidationCo NV in liquidatie?

The stock symbol for Crown LiquidationCo NV in liquidatie is "CNTGF."

What Is the Crown LiquidationCo NV in liquidatie Market Cap?

As of today, Crown LiquidationCo NV in liquidatie market cap is 1.79M.

What Is Crown LiquidationCo NV in liquidatie's Earnings Per Share (TTM)?

The Crown LiquidationCo NV in liquidatie EPS (TTM) is -1.26.

When Is the Next Crown LiquidationCo NV in liquidatie Earnings Date?

Crown LiquidationCo NV in liquidatie will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is CNTGF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Crown LiquidationCo NV in liquidatie Stock Split?

Crown LiquidationCo NV in liquidatie has split 0 times.

How Many Employees Does Crown LiquidationCo NV in liquidatie Have?

Crown LiquidationCo NV in liquidatie has 384 employees.

What is the current trading status of Crown LiquidationCo NV in liquidatie (CNTGF)?

As of 06 Aug 2025, Crown LiquidationCo NV in liquidatie (CNTGF) is trading at a price of 0.06, with a previous close of 0.06. The stock has fluctuated within a day range of 0.06 to 0.06, while its 52-week range spans from 0.01 to 0.71.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.